PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-11-21

Date Title Company
21-Nov-2023 Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment Symbiosis Pharmaceutical Services
21-Nov-2023 Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised Fresenius Medical Care AG & Co. KGaA
21-Nov-2023 Nano-sized probes reveal how cellular structure responds to pressure Science and Technology of Advanced Materials
21-Nov-2023 Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care. ATHENA
21-Nov-2023 Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing Immix Biopharma, Inc.
21-Nov-2023 iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference iTeos
21-Nov-2023 Cherwell welcomes new recruits as pharma environmental monitoring needs grow Cherwell
21-Nov-2023 Immunomodulator II patent granted in Japan Poolbeg Pharma plc
21-Nov-2023 UK Medical Devices Regulations: TÜV Rheinland is now a UK Approved Body according to UK MDR TÜV Rheinland
21-Nov-2023 Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics Myricx Bio
21-Nov-2023 Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM Vironova BioAnalytics
21-Nov-2023 EDX MEDICAL & THERMO FISHER SCIENTIFIC TO COLLABORATE ON DEVELOPMENT OF INNOVATIVE CANCER TESTS FOR GLOBAL MARKETS EDX Medical Group plc
21-Nov-2023 Biocomposites expands its product portfolio with the launch of SYNICEMTM spacers in the UK Biocomposites
21-Nov-2023 Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes ViCentra B.V.
21-Nov-2023 Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis Chiesi Group
21-Nov-2023 European Commission Approves pharmaand GmbH’s Rubraca® (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer pharmaand GmbH
21-Nov-2023 Eckert & Ziegler: Personnel Changes in the Management. Changes in the Executive Board and Supervisory Board. Eckert & Ziegler Strahlen- und Medizintechnik AG
21-Nov-2023 Global Hemostasis Products Industry Estimated to Surpass US$2.65 Billion by 2033, at a CAGR of 5.3% | FMI Insights MARKITWIRED
21-Nov-2023 Global Throat Sprays Industry to Surge, Anticipated US$598.3 Million by 2033 at a 2.1% CAGR | FMI Analysis MARKITWIRED
21-Nov-2023 Global Radiation Therapy Software Industry reaching a robust value of US$ 847.9 Million, at a CAGR of 8.20%. By 2032 MARKITWIRED